Sarah is the founder and CEO of Daphnia Labs, a drug discovery startup using machine learning to screen for aging-modulating drugs in vivo. Previously, she has built machine learning tools for biotech, autonomous vehicles, and cybersecurity. She received her PhD in math from Yale in 2015, focusing on manifold learning with applications to systems biology.
Related Organizations
Articles from this author
September 17, 2025
[Mountain View, September 17, 2025] — Lifespan Research Institute (LRI) today announced the launch of the Public Longevity Group (PLG), a new initiative focused on bridging the cultural gap between scientific breakthroughs in aging and their public acceptance. To kickstart its work, PLG has opened a crowdfunding campaign to develop tools that measure and strengthen...

